SCHEMBL13637150

SCHEMBL13637150

O=C(O)COc1ccc(OCCCOc2cnc(Cl)cc2-n2nc3ccccc3n2)cc1Cl

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 4/20 0.44
ALDH1A1 P00352 4/20 0.44
TDP1 Q9NUW8 4/20 0.44
KDM4E B2RXH2 3/20 0.44
NPC1 O15118 3/20 0.44
RAB9A P51151 3/20 0.44
MAPT P10636 2/20 0.44
PPARG P37231 8/20 0.44
PPARD Q03181 6/20 0.44
FFAR1 O14842 2/20 0.44
POLB P06746 1/20 0.44
PPARA Q07869 7/20 0.43
CYP2C19 P33261 2/20 0.43
CYP1A2 P05177 1/20 0.43
CYP2C9 P11712 1/20 0.43
SMN1; SMN2 Q16637 2/20 0.41
NPSR1 Q6W5P4 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
LMNA P02545 1/20 0.39
KMT2A Q03164 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13441819 0.91 KDM4E (0.50) HPGDALDH1A1TDP1KDM4ENPC1
SCHEMBL13637151 0.86 PPARG (0.46) HPGDALDH1A1TDP1KDM4ENPC1
SCHEMBL13441633 0.86 PPARG (0.46) HPGDALDH1A1TDP1KDM4ENPC1
SCHEMBL3587102 0.85 TDP1 (0.49) HPGDALDH1A1TDP1KDM4ENPC1
SCHEMBL13637152 0.84 PPARG (0.45) HPGDALDH1A1TDP1KDM4ENPC1
SCHEMBL13637206 0.83 LTB4R (0.45) HPGDALDH1A1TDP1KDM4ENPC1
SCHEMBL3593824 0.80 PPARG (0.51) HPGDALDH1A1TDP1KDM4ENPC1
SCHEMBL13637253 0.76 PPARD (0.59) HPGDALDH1A1TDP1KDM4ENPC1
SCHEMBL13637196 0.76 KDM4E (0.53) HPGDALDH1A1TDP1KDM4ENPC1
SCHEMBL13440569 0.76 KDM4E (0.51) HPGDALDH1A1TDP1KDM4ENPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7622491-B2 Type 2 diabetes, atherosclerosis, cardiovascular disease, Syndrome X; carboxylic acids with dialkyldiether or thioether linking groups e.g. {4-[3-(2-Benzotriazol-2-yl-4-chloro-phenoxy)-propoxy]-phenyl}-acetic acid and {4-[3-(2-benzotriazol-2-yl-4-thiophen-2-yl-phenoxy)-propoxy]-phenyl}-acetic acid METABOLEX INC. (US) 2009-11-24 US disclosed